van Dongen GA - Search Results

1

Molecular Drug Imaging: ⁸⁹Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.

Jansen MH, Veldhuijzen van Zanten SEM, van Vuurden DG, Huisman MC, Vugts DJ, Hoekstra OS, van Dongen GA, Kaspers GL. Jansen MH, et al. Among authors: van dongen ga, van vuurden dg. J Nucl Med. 2017 May;58(5):711-716. doi: 10.2967/jnumed.116.180216. Epub 2016 Oct 20. J Nucl Med. 2017. PMID: 27765855 Free article. Clinical Trial.

2

Clinical imaging of head and neck cancer with technetium-99m-labeled monoclonal antibody E48 IgG or F(ab')2.

de Bree R, Roos JC, Quak JJ, den Hollander W, van den Brekel MW, van der Wal JE, Tobi H, Snow GB, van Dongen GA. de Bree R, et al. Among authors: van den brekel mw, van der wal je, van dongen ga. J Nucl Med. 1994 May;35(5):775-83. J Nucl Med. 1994. PMID: 8176458 Free article.

3

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Among authors: van dongen ga. J Nucl Med. 2003 Aug;44(8):1271-81. J Nucl Med. 2003. PMID: 12902418 Free article.

4

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. Among authors: van eerd j, van dongen ga. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

5

Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.

Postema EJ, Börjesson PK, Buijs WC, Roos JC, Marres HA, Boerman OC, de Bree R, Lang M, Munzert G, van Dongen GA, Oyen WJ. Postema EJ, et al. Among authors: van dongen ga. J Nucl Med. 2003 Oct;44(10):1690-9. J Nucl Med. 2003. PMID: 14530488 Free article. Clinical Trial.

6

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.

Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Brouwers A, et al. Cancer Biother Radiopharm. 2004 Apr;19(2):155-63. doi: 10.1089/108497804323071922. Cancer Biother Radiopharm. 2004. PMID: 15186595 Free article.

7

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Verel I, et al. Among authors: van dongen ga. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1645-52. doi: 10.1007/s00259-004-1632-8. Epub 2004 Jul 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15290121

8

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA. Verel I, et al. Among authors: van dongen ga. J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. J Nucl Med. 2005. PMID: 15653665 Free article. Review.

9

(89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.

Perk LR, Visser GW, Vosjan MJ, Stigter-van Walsum M, Tijink BM, Leemans CR, van Dongen GA. Perk LR, et al. Among authors: van dongen ga. J Nucl Med. 2005 Nov;46(11):1898-906. J Nucl Med. 2005. PMID: 16269605 Free article.

10

Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.

Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA. Tijink BM, et al. Among authors: van dongen ga. J Nucl Med. 2006 Jul;47(7):1127-35. J Nucl Med. 2006. PMID: 16818947 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters